Ifit2 deficiency restricts microglial activation and leukocyte migration following murine coronavirus (m-CoV) CNS infection.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
11 2020
Historique:
received: 30 06 2020
accepted: 02 10 2020
revised: 15 12 2020
pubmed: 1 12 2020
medline: 30 12 2020
entrez: 30 11 2020
Statut: epublish

Résumé

The interferon-induced tetratricopeptide repeat protein (Ifit2) protects mice from lethal neurotropic viruses. Neurotropic coronavirus MHV-RSA59 infection of Ifit2-/- mice caused pronounced morbidity and mortality accompanied by rampant virus replication and spread throughout the brain. In spite of the higher virus load, induction of many cytokines and chemokines in the brains of infected Ifit2-/- mice were similar to that in wild-type mice. In contrast, infected Ifit2-/- mice revealed significantly impaired microglial activation as well as reduced recruitment of NK1.1 T cells and CD4 T cells to the brain, possibly contributing to the lack of viral clearance. These two deficiencies were associated with a lower level of microglial expression of CX3CR1, the receptor of the CX3CL1 (Fractalkine) chemokine, which plays a critical role in both microglial activation and leukocyte recruitment. The above results uncovered a new potential role of an interferon-induced protein in immune protection.

Identifiants

pubmed: 33253295
doi: 10.1371/journal.ppat.1009034
pii: PPATHOGENS-D-20-01417
pmc: PMC7738193
doi:

Substances chimiques

Apoptosis Regulatory Proteins 0
Cytokines 0
Ifit2 protein, mouse 0
RNA-Binding Proteins 0
Interferons 9008-11-1

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009034

Subventions

Organisme : NCI NIH HHS
ID : R01 CA068782
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Front Immunol. 2014 Mar 10;5:94
pubmed: 24653722
Nature. 1997 Feb 13;385(6617):640-4
pubmed: 9024663
Radiology. 2020 Aug;296(2):E119-E120
pubmed: 32228363
Biofactors. 2009 Jan-Feb;35(1):14-20
pubmed: 19319841
J Exp Med. 2005 Aug 1;202(3):415-24
pubmed: 16043521
Am J Pathol. 2010 Nov;177(5):2549-62
pubmed: 20864679
J Virol. 2014 Dec;88(23):13593-601
pubmed: 25231314
Nat Med. 1996 Nov;2(11):1174-8
pubmed: 8898734
PLoS Pathog. 2011 Jan 06;7(1):e1001258
pubmed: 21253575
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
J Neurosci Res. 2003 Jul 1;73(1):81-8
pubmed: 12815711
Curr Opin Virol. 2011 Dec;1(6):519-25
pubmed: 22328912
Science. 2011 Sep 9;333(6048):1456-8
pubmed: 21778362
J Virol. 2008 Sep;82(17):8882-6
pubmed: 18579591
Virology. 1992 Nov;191(1):502-5
pubmed: 1413524
Neuron. 2010 Oct 6;68(1):19-31
pubmed: 20920788
Rheumatology (Oxford). 2007 Sep;46(9):1422-7
pubmed: 17616549
Nat Med. 2020 Apr;26(4):453-455
pubmed: 32284614
Mol Interv. 2010 Oct;10(5):263-70
pubmed: 21045240
J Virol. 2017 Aug 10;91(17):
pubmed: 28637751
J Virol. 2000 Oct;74(19):8913-21
pubmed: 10982334
J Virol. 1992 Apr;66(4):1841-8
pubmed: 1312608
Transl Neurodegener. 2018 Dec 21;7:35
pubmed: 30607245
J Immunol. 2008 Feb 15;180(4):2641-9
pubmed: 18250476
PLoS Pathog. 2010 Jul 29;6(7):e1000937
pubmed: 20686655
Glia. 2002 Mar 15;37(4):314-27
pubmed: 11870871
Biol Chem. 2019 Apr 24;400(5):651-661
pubmed: 30352020
ACS Chem Neurosci. 2020 May 6;11(9):1206-1209
pubmed: 32320211
J Virol. 2014 Jan;88(2):1051-64
pubmed: 24198415
Curr Opin Pharmacol. 2016 Feb;26:1-9
pubmed: 26410391
Nat Neurosci. 2018 Oct;21(10):1359-1369
pubmed: 30258234
J Virol. 2014 Sep;88(18):10303-11
pubmed: 24991014
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
Brain Res Bull. 2019 Mar;146:12-21
pubmed: 30496784
Nat Neurosci. 2006 Jul;9(7):917-24
pubmed: 16732273
J Virol. 2007 Jul;81(13):7189-99
pubmed: 17459917
J Immunol. 2000 Apr 15;164(8):4313-20
pubmed: 10754331
Eur J Immunol. 2006 Mar;36(3):613-22
pubmed: 16479546
Cytokine Growth Factor Rev. 2014 Oct;25(5):543-50
pubmed: 24909568
Annu Rev Virol. 2015 Nov;2(1):549-72
pubmed: 26958928
Blood. 2009 Jan 22;113(4):767-8
pubmed: 19164504
J Virol. 2008 Dec;82(24):12325-34
pubmed: 18922871
J Virol. 2013 Aug;87(15):8363-71
pubmed: 23740986
Brain Behav Immun. 2010 Oct;24(7):1190-201
pubmed: 20570721
Life Sci Alliance. 2019 Dec 2;2(6):
pubmed: 31792059
J Virol. 1997 Jul;71(7):5148-60
pubmed: 9188582
Curr Opin Immunol. 1994 Dec;6(6):865-73
pubmed: 7710711
J Virol. 2008 Jun;82(11):5519-26
pubmed: 18385249
J Neuropathol Exp Neurol. 2003 Sep;62(9):899-907
pubmed: 14533779
FEBS Lett. 1998 Jun 12;429(2):167-72
pubmed: 9650583
J Neurosci. 2009 Aug 19;29(33):10272-80
pubmed: 19692601
Blood. 1997 Aug 1;90(3):909-28
pubmed: 9242519
PLoS Pathog. 2012;8(5):e1002712
pubmed: 22615570
Brain Behav Immun. 2020 Jul;87:18-22
pubmed: 32240762
Cell. 1997 Nov 14;91(4):521-30
pubmed: 9390561
J Neurovirol. 2002 Oct;8(5):381-91
pubmed: 12402164
Annu Rev Immunol. 1994;12:593-633
pubmed: 8011292
J Immunol. 2000 Feb 1;164(3):1333-9
pubmed: 10640747
J Virol. 2008 Oct;82(20):9829-38
pubmed: 18667505
J Virol. 2020 Jul 1;94(14):
pubmed: 32404525
Cell Host Microbe. 2020 Jun 10;27(6):883-890.e2
pubmed: 32407669
Open Biol. 2013 Dec 18;3(12):130181
pubmed: 24352739
Nat Microbiol. 2020 Dec;5(12):1490-1503
pubmed: 32839537
J Cell Biochem. 2004 May 15;92(2):213-22
pubmed: 15108349
Front Cell Neurosci. 2013 Mar 18;7:26
pubmed: 23507975
Cell Res. 2012 Oct;22(10):1407-9
pubmed: 22964712
PLoS One. 2012;7(5):e36140
pubmed: 22570697
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Mol Immunol. 2019 Apr;108:23-33
pubmed: 30776726
J Virol. 2015 Mar;89(5):2462-8
pubmed: 25428874
EBioMedicine. 2020 May;55:102763
pubmed: 32361250
Adv Immunol. 1994;55:97-179
pubmed: 8304236
Curr Opin Virol. 2014 Jun;6:40-6
pubmed: 24713352
J Virol. 2000 Oct;74(19):9206-13
pubmed: 10982367
Genes Immun. 2003 Apr;4(3):177-86
pubmed: 12700592
Clin Dev Immunol. 2013;2013:510396
pubmed: 23864878
J Biol Chem. 2019 May 17;294(20):8064-8087
pubmed: 30824541
Nat Rev Immunol. 2013 Jan;13(1):46-57
pubmed: 23237964
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15623-8
pubmed: 9861020
Front Cell Neurosci. 2018 Sep 27;12:323
pubmed: 30319362
J Exp Med. 1998 Oct 19;188(8):1413-9
pubmed: 9782118

Auteurs

Jayasri Das Sarma (J)

Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Ohio, United States of America.
Department of Biological Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, West Bengal, India.

Amy Burrows (A)

Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Ohio, United States of America.

Patricia Rayman (P)

Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Ohio, United States of America.

Mi-Hyun Hwang (MH)

Department of Neurosciences, Cleveland Clinic, Ohio, United States of America.

Soumya Kundu (S)

Department of Biological Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, West Bengal, India.

Nikhil Sharma (N)

Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Ohio, United States of America.

Cornelia Bergmann (C)

Department of Neurosciences, Cleveland Clinic, Ohio, United States of America.

Ganes C Sen (GC)

Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Ohio, United States of America.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH